• Barat LM, Himonga B, Nkunika S et al. (1998) A systematic approach to the development of a rational malaria treatment policy in Zambia. Tropical Medicine and International Health 3, 535542.
  • Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R & Campbell CC (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932937.
  • Bloland PB & Ettling M (1999) Making malaria-treatment policy in the face of drug resistance. Annals of Tropical Medicine and Parasitology 93, 523.
  • Campbell CC (1991) Challenges facing antimalarial therapy in Africa. Journal of Infectious Diseases 163, 12071211.
  • Delacollette C et al. (1983) Response to chloroquine of infections with Plasmodium falciparum in the Kivu region. Annales de la Societe belge de Medicine Tropicale 53, 171173.
  • Greenwood BM (1987) Asymptomatic malaria infections, do they matter? Parasitology Today 3, 206214.
  • Greenwood BM et al. (1987) Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 478486.
  • Kitua AY (2000) Antimalarial drug policy: making systematic change. Lancet 354, Supplement 4, 821–823.
  • Ringwald P, Same Ekobo A, Keundjian A et al. (2000a) Chemoresistance of P. falciparum in urban areas of Yaounde, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon. Tropical Medicine and International Health 5, 612619.
  • Ringwald P, Keundjian A, Same Ekobo A & Basco LK (2000b) Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine–pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde, Cameroon. Tropical Medicine and International Health 5, 620627.
  • Shapira A et al. (1993) Malaria: living with drug resistance. Parasitology Today 9, 176184.
  • Sudre P, Breman JG, McFarland D & Koplan JP (1992) Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. International Journal of Epidemiology 21, 146154.
  • Trape JF et al. (1998) Impact of chloroquine on malaria mortality. CR Acad Sc. III 321, 689697.
  • Watkins WM, Mberu EK, Winstanley PA & Plowe CV (1997) The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic pharmocokinetic analyses. Parasitology Today 13, 459464.
  • White NJ, Nosten F, Looareesuwan S et al. (1999) Averting a malaria disaster. Lancet 353, 19651967.
  • WHO (1996) Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. World Health Organization, Geneva (WHO/MAL/96.1077).